Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 408 of 1,261
  1. US 10729788

    Compositions and methods for treating or ameliorating neuroinflammation, neurodegeneration, neuropathic pain, and migraine

    The Regents of the University of California · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  2. US 10730834

    Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof

    Shuttle Pharmaceuticals, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  3. US 10729781

    LGR4 specific monoclonal antibodies and methods of their use

    The Board of Regents of the University of Texas System · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  4. US 10729768

    Combination of anti-CD20 antibody and PI3 kinase selective inhibitor

    TG Therapeutics, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  5. US 10729774

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  6. US 10729767

    Humanized anti-C1s antibodies and methods of inhibiting C1s cleavage

    Bioverativ USA Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  7. US 10729756

    Viable viruses with foreign tags

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  8. US 10729725

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  9. US 10729747

    Methods and compositions for modulating myofibroblast activities

    The Regents of the University of California · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  10. US 10729696

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  11. US 10729736

    Composition for reducing blood lipid and use thereof as healthcare dietary supplements

    INFINITUS (CHINA) COMPANY LTD. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  12. US 10729693

    Compositions and methods for the treatment of endometriosis

    The Board of Regents of the University of Texas System · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  13. US 10729650

    Skin punch biopsy and wound-debridgement training model

    United States of America as represented by the Secretary of the Air Force · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  14. US 10729668

    Ketobutyrate compounds and compositions for treating age-related symptoms and diseases

    The Regents of the University of California · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  15. US 10729676

    Opioid agonist peptides and uses thereof

    Protagonist Therapeutics, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  16. US 10729643

    Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  17. US 10729624

    High-ultraviolet absorption lignin/chemical sun-screening agent microcapsule and preparation method therefor

    South China University of Technology · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  18. US 10729641

    Ordered macroporous materials

    Regents of the University of Minnesota · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  19. US 10729534

    Methods of treating a musculoskeletal tissue interface injury using decellularized composite tissue bioscaffolds

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  20. US 10731131

    Dendritic cell generator

    Northwestern University · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  21. US 10729688

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  22. US 2020239601

    CROSSLINKED POLYMERIC NETWORK AND USE THEREOF

    BAUSCH & LOMB [US] · Granted Jul 30, 2020 · Expires Jul 25, 2040

    granted
  23. US 10723777

    Peptide having anti-obesity and anti-diabetes efficacy and use thereof

    CAREGEN CO., LTD. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted
  24. US 10723718

    Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.